TY - JOUR
KW - Analgesics, Opioid/poisoning
KW - Animals
KW - Drug Overdose/drug therapy/epidemiology
KW - fentanyl analogs
KW - Fentanyl/analogs & derivatives/poisoning
KW - Harm Reduction
KW - Humans
KW - Illicitly manufactured fentanyl
KW - Naloxone/administration & dosage/pharmacokinetics
KW - Narcotic Antagonists/administration & dosage/pharmacokinetics
KW - occupational exposure
KW - opioid abuse
KW - opioid overdose
KW - Opioid-Related Disorders/complications
KW - Street Drugs/poisoning
KW - take-home naloxone
KW - United States
AU - H. K. Kim
AU - N. J. Connors
AU - M. E. Mazer-Amirshahi
A1 - 
BT - Expert opinion on drug safety
C5 - Opioids & Substance Use
CP - 6
CY - England
DO - 10.1080/14740338.2019.1613372
IS - 6
JF - Expert opinion on drug safety
PP - England
PY - 2019
SN - 1744-764X; 1474-0338
SP - 465
EP - 475
EP - 
T1 - The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs
T2 - Expert opinion on drug safety
TI - The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs
U1 - Opioids & Substance Use
U2 - 31033357
U3 - 10.1080/14740338.2019.1613372
VL - 18
VO - 1744-764X; 1474-0338
Y1 - 2019
ER -